Surrozen Inc: Phase 1a Trial of Szn-043 Demonstrated Evidence of Target Engagement and Wnt-Pathway Mediated Pharmacodynamic Effects in Liver
Surrozen公司:Szn-043的1a試驗顯示靶向作用證據和Wnt通路介導的肝臟藥效學效應
Surrozen Inc: Phase 1a Trial of Szn-043 Demonstrated Evidence of Target Engagement and Wnt-Pathway Mediated Pharmacodynamic Effects in Liver
Surrozen公司:Szn-043的1a試驗顯示靶向作用證據和Wnt通路介導的肝臟藥效學效應
譯文內容由第三人軟體翻譯。